VIDEO: Oral drugs tackle hepatitis C genotypes 2, 3

CHICAGO – The oral drug duo of sofosbuvir and ribavirin produced good cure rates in a study of 419 patients with hepatitis C genotype 2 or 3. Dr. Bruce R. Bacon, who was not involved in the study,...

Field of Interest: Gastroentero...
Type: News Item

VIDEO: Oral drugs tackle hepatitis C genotypes 2, 3

CHICAGO – The oral drug duo of sofosbuvir and ribavirin produced good cure rates in a study of 419 patients with hepatitis C genotype 2 or 3. Dr. Bruce R. Bacon, who was not involved in the study,...

Field of Interest: Endocrinology
Type: News Item

EXCLUSIVE VIDEO: MERS – What physicians need to know

VANCOUVER, B.C. – Dr. Daniel C. Payne has been investigating the Middle East Respiratory Syndrome coronavirus since the first case was reported in the Arabian Peninsula nearly 2 years ago. An...

Field of Interest: Rheumatology
Type: News Item

Interferon-free regimen improves response in HCV

CHICAGO – Treating patients with hepatitis C virus genotype 1a or 1b with 12 weeks of an experimental interferon-free, triple-drug oral regimen produced good sustained virologic response rates with...

Field of Interest: Gastroentero...
Type: News Item

Interferon-free regimen improves response in HCV

CHICAGO – Treating patients with hepatitis C virus genotype 1a or 1b with 12 weeks of an experimental interferon-free, triple-drug oral regimen produced good sustained virologic response rates with...

Field of Interest: Infectious diseases
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness